Research, Development, And Testing Services - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Research, Development, And Testing Services - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Research, Development, And Testing Services
Corporate Insider Buy Sell Ratio (Insider Count) - Research, Development, And Testing Services
Research, Development, And Testing Services - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-01-31 NOTV / Inotiv, Inc. 4 Sagartz John E S - Sale D 4.4754 -2,118
2025-01-31 NOTV / Inotiv, Inc. 4 Krupp Jeffrey Arthur S - Sale D 4.4809 -2,036
2025-01-31 CRL / Charles River Laboratories International, Inc. 4 Knell Michael Gunnar F - Taxes D 165.57 -282
2025-01-31 CRL / Charles River Laboratories International, Inc. 4 LaPlume Joseph W F - Taxes D 165.57 -846
2025-01-31 CRL / Charles River Laboratories International, Inc. 4 Parisotto Shannon M F - Taxes D 165.57 -471
2025-01-31 CRL / Charles River Laboratories International, Inc. 4 FOSTER JAMES C F - Taxes D 165.57 -6,827
2025-01-31 CRL / Charles River Laboratories International, Inc. 4 Creamer Victoria L F - Taxes D 165.57 -791
2025-01-31 CRL / Charles River Laboratories International, Inc. 4 Girshick Birgit F - Taxes D 165.57 -1,025
2025-01-31 CRL / Charles River Laboratories International, Inc. 4 Pease Flavia F - Taxes D 165.57 -914
2025-01-31 CRL / Charles River Laboratories International, Inc. 4 Pease Flavia A - Award D 2,704
2025-01-31 CRL / Charles River Laboratories International, Inc. 4 LaPlume Joseph W A - Award D 2,738
2025-01-31 INCY / Incyte Corporation 4 Heeson Lee A - Award D 6,331
2025-01-31 INCY / Incyte Corporation 4 Morrissey Michael James A - Award D 10,552
2025-01-31 CRL / Charles River Laboratories International, Inc. 4 FOSTER JAMES C A - Award D 19,608
2025-01-31 CRL / Charles River Laboratories International, Inc. 4 Creamer Victoria L A - Award D 2,468
2025-01-31 CRL / Charles River Laboratories International, Inc. 4 Knell Michael Gunnar A - Award D 811
2025-01-31 CRL / Charles River Laboratories International, Inc. 4 Parisotto Shannon M A - Award D 1,758
2025-01-31 CRL / Charles River Laboratories International, Inc. 4 Girshick Birgit A - Award D 4,057
2025-01-30 OABI / OmniAb, Inc. 4 HIGGINS JOHN L M - Exercise D 13,172
2025-01-28 IQV / IQVIA Holdings Inc. 4 Sherbet Eric F - Taxes D 203.43 -605
2025-01-28 IQV / IQVIA Holdings Inc. 4 BOUSBIB ARI F - Taxes D 203.43 -10,500
2025-01-28 IQV / IQVIA Holdings Inc. 4 STAUB W RICHARD F - Taxes D 203.43 -479
2025-01-28 IQV / IQVIA Holdings Inc. 4 Bruehlman Ronald E F - Taxes D 203.43 -2,201
2025-01-28 IQV / IQVIA Holdings Inc. 4 Cherofsky Keriann F - Taxes D 203.43 -176
2025-01-28 IQV / IQVIA Holdings Inc. 4 Patel Bhavik F - Taxes D 203.43 -612
2025-01-28 IQV / IQVIA Holdings Inc. 4 Cherofsky Keriann A - Award D 441
2025-01-28 IQV / IQVIA Holdings Inc. 4 Patel Bhavik A - Award D 1,299
2025-01-28 IQV / IQVIA Holdings Inc. 4 Cherofsky Keriann A - Award D 2,457
2025-01-28 IQV / IQVIA Holdings Inc. 4 STAUB W RICHARD A - Award D 1,571
2025-01-28 IQV / IQVIA Holdings Inc. 4 Bruehlman Ronald E A - Award D 6,286
2025-01-28 IQV / IQVIA Holdings Inc. 4 BOUSBIB ARI A - Award D 22,000
2025-01-28 IQV / IQVIA Holdings Inc. 4 Sherbet Eric A - Award D 2,356
2025-01-27 MXCT / MaxCyte, Inc. 4 Johnston John Joseph S - Sale D 4.645 -3,000
2025-01-27 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 2.932 3,000
2025-01-21 OABI / OmniAb, Inc. 4 Berkman Charles S S - Sale D 3.24 -25,489
2025-01-21 INCY / Incyte Corporation 4 Stein Steven H S - Sale D 72.69 -12,352
2025-01-21 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A S - Sale D 3.24 -15,526
2025-01-21 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W S - Sale D 3.24 -41,811
2025-01-21 INCY / Incyte Corporation 4 Morrissey Michael James F - Taxes D 73.47 -429
2025-01-17 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W A - Award D 77,003
2025-01-17 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A A - Award D 27,585
2025-01-17 OABI / OmniAb, Inc. 4 Berkman Charles S A - Award D 45,294
2025-01-15 INCY / Incyte Corporation 4 Stamoulis Christiana F - Taxes D 72.46 -3,672
2025-01-15 INCY / Incyte Corporation 4 Flannelly Barry P F - Taxes D 72.46 -3,158
2025-01-15 INCY / Incyte Corporation 4 Stein Steven H F - Taxes D 72.46 -10,692
2025-01-15 INCY / Incyte Corporation 4 Morrissey Michael James F - Taxes D 72.46 -908
2025-01-13 MXCT / MaxCyte, Inc. 4 Sandoval David I. S - Sale D 4.5391 -4,466
2025-01-10 BIAF / bioAffinity Technologies, Inc. 4 Zannes Timothy P A - Award D 8,641
2025-01-10 BIAF / bioAffinity Technologies, Inc. 4 GIRGENTI STEVEN A - Award D 14,814
2025-01-10 BIAF / bioAffinity Technologies, Inc. 4 Reveles Xavier Trinidad A - Award D 21,604
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)